Technical Analysis for ERGO - Ergomed Plc

Grade Last Price % Change Price Change
C 1330.0 -2.92% -40.00
ERGO closed down 2.92 percent on Thursday, December 2, 2021, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ERGO trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 200 DMA Bullish -2.92%
Stochastic Buy Signal Bullish -2.92%
Oversold Stochastic Weakness -2.92%
Fell Below 200 DMA Bearish 3.91%
Volume Surge Other 3.91%
Lower Bollinger Band Walk Weakness 3.91%
Down 3 Days in a Row Weakness 3.91%
Oversold Stochastic Weakness 3.91%
Older End-of-Day Signals for ERGO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 1 day ago
Down 2% 1 day ago
Down 1% 1 day ago
Gapped Down (Partial) 1 day ago
Fell Below 10 DMA 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ergomed Plc Description

Ergomed plc is a provider of drug development services to the pharmaceutical industry. The Company operates through two segments: clinical research services (CRS), and drug safety and medical information services (DS&MI). It provides a range of clinical trial planning, management and monitoring services. It is focused on oncology, neurology and immunology, and the development of orphan drugs. It has two businesses: Services Business and Co-Development Business. The Services Business is a clinical research business providing services to the pharmaceutical and biotechnology industry. The Co-Development Business is a portfolio of partnerships with pharmaceutical and biotechnology companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including out licensing milestones, as well as sales of the product. It provides clinical development, trial management and pharmacovigilance services to over 100 clients.


Sector: Healthcare
Industry: Biotechnology
Keywords: Health Information Pharmaceutical Revenue Biotechnology Ships Clinic Planning Monitoring Safety Partnerships Drugs Oncology Clinical Trial Pharmaceutical Industry Immunology Clinical Research Drug Development Search Service Biotechnology Companies Pharmaceuticals Policy Clinical Pharmacology Biotechnology Industry Clinical Research Services Contract Research Organizations Medical Information Services Parexel

Is ERGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1585.0
52 Week Low 885.0
Average Volume 56,347
200-Day Moving Average 1284.08
50-Day Moving Average 1405.20
20-Day Moving Average 1418.25
10-Day Moving Average 1352.50
Average True Range 74.32
ADX 17.59
+DI 14.32
-DI 19.27
Chandelier Exit (Long, 3 ATRs) 1362.05
Chandelier Exit (Short, 3 ATRs) 1472.95
Upper Bollinger Bands 1576.47
Lower Bollinger Band 1260.03
Percent B (%b) 0.22
BandWidth 22.31
MACD Line -32.29
MACD Signal Line -18.46
MACD Histogram -13.8361
Fundamentals Value
Market Cap 647.95 Million
Num Shares 48.7 Million
EPS 12.50
Price-to-Earnings (P/E) Ratio 106.40
Price-to-Sales 5.47
Price-to-Book 8.98
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1414.38
Resistance 3 (R3) 1415.42 1388.33 1400.31
Resistance 2 (R2) 1388.33 1366.85 1387.81 1395.62
Resistance 1 (R1) 1359.17 1353.57 1373.75 1358.13 1390.94
Pivot Point 1332.08 1332.08 1339.38 1331.56 1332.08
Support 1 (S1) 1302.92 1310.60 1317.50 1301.88 1269.06
Support 2 (S2) 1275.83 1297.32 1275.31 1264.38
Support 3 (S3) 1246.67 1275.83 1259.69
Support 4 (S4) 1245.63